Status:
WITHDRAWN
Whole-body MRI for the Detection of Metastasis
Lead Sponsor:
Norwegian University of Science and Technology
Conditions:
Breast Cancer
Metastases
Eligibility:
FEMALE
18-95 years
Brief Summary
Develop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.
Eligibility Criteria
Inclusion
- \- Cancer patient
Exclusion
- Poor general condition
- Pacemaker or other MRI contraindications
Key Trial Info
Start Date :
March 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02183597
Start Date
March 1 2016
End Date
March 1 2018
Last Update
August 10 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.